Carr Douglas 4
4 · Century Therapeutics, Inc. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
Century Therapeutics (IPSC) SVP Carr Douglas Sells 247 Shares
What Happened
Carr Douglas, Senior Vice President of Finance & Operations at Century Therapeutics (IPSC), reported the sale of 247 shares on 2026-03-09 at $2.54 per share, generating proceeds of approximately $626. The transaction is reported as a sale (S) and was conducted to satisfy tax withholding tied to the vesting of restricted stock units.
Key Details
- Transaction date and price: 2026-03-09 — 247 shares sold at $2.54 each.
- Total proceeds: ~ $626.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnote: The sale was automatic to cover tax withholding obligations related to RSU vesting and was not at the Reporting Person’s discretion (Footnote F1).
- Filing/Timeliness: Form filed 2026-03-11 reporting a 2026-03-09 transaction — appears timely based on the filing date.
Context
This was a tax-withholding sale tied to RSU vesting (automatic), which is common and typically does not indicate an insider’s change in view about the company. The dollar amount is small, so it’s generally not meaningful as a market-sentiment signal for investors.
Insider Transaction Report
Form 4
Carr Douglas
SVP Finance & Operations
Transactions
- Sale
Common Stock
[F1]2026-03-09$2.54/sh−247$626→ 514,304 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Signature
/s/ Douglas Carr|2026-03-11